Navigation Links
GlaxoSmithKline Reports Q4 and Year End Results 2008
Date:2/5/2009

LONDON, February 5 /PRNewswire-FirstCall/ -- In a video interview Andrew Witty, GlaxoSmithKline CEO, described the pharmaceutical group's results as "robust" in a year that was "always going to be challenging".

GSK also announced that it will cease providing EPS guidance, to allow a focus on longer term strategic goals.

Describing 2008 as a strategic turning point for GSK Mr Witty said: "We started to make very clear what it would take to really make this company strong over the next few years and how we intend to ensure that we build a business, which can really prosper in a challenging environment."

GSK also announced expanded restructuring savings that the company says will be the catalyst to move from the old business model to the new business model.

The interview is available now on http://w3.cantos.com/glaxosmithkline .

It's free to view. All you need to do is register at http://www.cantos.com. Cantos.com, the online financial broadcaster, features in-depth interviews, documentaries and webcasts with senior company executives.

If you would like to contact us, please email enquiries@cantos.com or phone +44-207-936-1333.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
3. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
4. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
5. GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
6. BioWa Announces Licensing of BioWas POTELLIGENT(R) Technology by GlaxoSmithkline for Use in Antibody Research and Development
7. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
8. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
9. GlaxoSmithKline Announces Data on TYKERB(R) (Lapatinib) Plus Capecitabine for the Treatment of HER2 Positive Breast Cancer Brain Metastases
10. Vaccinex Antibody Licensed to GlaxoSmithKline
11. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... and MONTREAL, Dec. 1 /PRNewswire-FirstCall/ - Bio... (OTCPK: ICBT), announced today that the company h...Inc., of Canada for the manufacturing of the TOG,S...he U.S. ,, "We have seen the disastrous results...es and packaged salads in the past" said Don Saund...
(Date:12/1/2009)... iCardiac now provides services to three out... Rochester, NY (PRWEB) Dece...bal leader in advanced cardiac core lab services a...armaceutical company has selected iCardiac as a pr... will provide Highly Automated QT(sm) and Dynamic ...
(Date:11/30/2009)... KING OF PRUSSIA, Pa., Nov. 30 Ca...ializing in interactive marketing services and so...ed the launch of its HATCH Consulting servic...igning strategic experts across a range of emergin...H Consulting team is committed to guiding companie...
(Date:11/30/2009)...STERDAM, November 30 Biopharmaceut...e first patients have been enrolled in its,multina...The study is,designed to show reduction in transpl...ng an allogeneic stem cell transplantation with a ... patients eligible for an allogeneic,stem cell tra...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2
...ire-FirstCall/ -- Yongye Biotechnology,Internation...e "Company"),a leading developer, producer and dis...e People,s Republic of China, today announced its ...30, 2008., Third Quarter 2008 Highlights -- Rev... the third quarter of 2007 -- Gross profit wa...
...essor Apparao Rao and his team are researching nan...d and alert us to toxic chemicals or gases in the ... potential is there for real-time chemical alerts ... home. , "The ability to build extremely small de...y seen so far in science-fiction movies," Rao said...
...RNewswire-FirstCall/ -- China Biologic,Products, I...the,"Company"), one of the leading plasma-based ph... China ("PRC"), today reported financial results f...Third Quarter 2008 Highlights -- Revenues increas... profit increased 45.1% to $9.7 million over the t...
Other Biology Technology:Yongye Biotechnology Announces Record Third Quarter Results 2Yongye Biotechnology Announces Record Third Quarter Results 3Yongye Biotechnology Announces Record Third Quarter Results 4Yongye Biotechnology Announces Record Third Quarter Results 5Yongye Biotechnology Announces Record Third Quarter Results 6Yongye Biotechnology Announces Record Third Quarter Results 7Yongye Biotechnology Announces Record Third Quarter Results 8Yongye Biotechnology Announces Record Third Quarter Results 9Yongye Biotechnology Announces Record Third Quarter Results 10Yongye Biotechnology Announces Record Third Quarter Results 11Yongye Biotechnology Announces Record Third Quarter Results 12Clemson researchers advance nanoscale electromechanical sensors 2China Biologic Products Reports Strong Third Quarter 2008 Results 2China Biologic Products Reports Strong Third Quarter 2008 Results 3China Biologic Products Reports Strong Third Quarter 2008 Results 4China Biologic Products Reports Strong Third Quarter 2008 Results 5China Biologic Products Reports Strong Third Quarter 2008 Results 6China Biologic Products Reports Strong Third Quarter 2008 Results 7China Biologic Products Reports Strong Third Quarter 2008 Results 8China Biologic Products Reports Strong Third Quarter 2008 Results 9China Biologic Products Reports Strong Third Quarter 2008 Results 10China Biologic Products Reports Strong Third Quarter 2008 Results 11China Biologic Products Reports Strong Third Quarter 2008 Results 12China Biologic Products Reports Strong Third Quarter 2008 Results 13China Biologic Products Reports Strong Third Quarter 2008 Results 14China Biologic Products Reports Strong Third Quarter 2008 Results 15China Biologic Products Reports Strong Third Quarter 2008 Results 16
(Date:11/30/2009)... Take advantage of lower early bird registration r...oporosis congress of 2010 at http://www.iofwco-ec...congress of the International Osteoporosis Foundat...d Economic Aspects of Osteoporosis and Osteoarthri...und the world are expected to attend. The exciting...
(Date:11/30/2009)... A new research report published in the December 2...ay give men similar type of control over their fer... because scientists have found how and where andro...l sperm production and male fertility. This opens ...l" for men. The discovery also offers hope to thos...
(Date:11/26/2009)... Hammerhead sharks are some of the Ocean,s most di... why they have this strange head shape, says Mich...possible reason is the shark,s vision. ,Perhaps th...head shape, says McComb, giving the sharks excell...cording to McComb, there were two schools of thoug...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2Pederson Immigration Law Group Announces 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51347 1Pederson Immigration Law Group Announces 14th Annual J 1 H 1B Foreign Physician Immigration Conference and Job Fair Series 51347 2Earvin Magic Johnson and the Magic Johnson Foundation Give Students their Blueprint for Success at Annual Leadership Conference 51344 1Earvin Magic Johnson and the Magic Johnson Foundation Give Students their Blueprint for Success at Annual Leadership Conference 51344 2Savoring Happy Moments Helps Build Emotional Strength 51341 1Savoring Happy Moments Helps Build Emotional Strength 51341 2
...vaccine against HIV infection have been given a mu...obal HIV/AIDS Vaccine Enterprise,s,scientific stra...le,open-access global health journal PLoS Medicin...ternational alliance of,independent agencies and o...research. In June 2004, the G8 countries endorsed ...
...won a £261,000 grant to use the latest software to... stop influenza and some other diseases from repli... comes at a time when fears are rising that an inf...ld kill thousands of people. , Professor Ian Will...ork in April on a project that could help pharmace...
...t microarray-based experiments,reproductibility, ...st,these results? If I redo the same experiment in...H recently demonstrated that microarrays experime...gree of reproducibility , as long as standardized ...the scientific community (and the microarrays prod...
Other Biology News:A much-needed shot in the arm for HIV vaccine development 2A much-needed shot in the arm for HIV vaccine development 3Computers to be used to find blueprint for new influenza drug 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 2Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible 3
...DNA-topoisomersae II inhibitor (IC50 = 59.2 M). ...55658 Store at: RT CAS: 33419-42-0 Solu...[5R-[5alpha,5abeta,8aalpha,9beta(R*)]]-9-[(4,6-O-E...ahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo[3',4...
Rabbit Anti-Human POU2F2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human NAP-2 Monoclonal Antibody, Unconjugated, Clone 5C7 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-IKKbeta / IKK-2 Polyclonal Antibody, Unconjugated from BioVision
Biology Products: